Detalhe da pesquisa
1.
Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.
Cancer Immunol Immunother
; 71(4): 979-987, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34467417
2.
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Cancer Immunol Immunother
; 69(5): 813-824, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055920
3.
Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16high CD62Ldim immunosuppressive subset.
Int J Cancer
; 144(5): 1128-1134, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30178523
4.
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Cancer Immunol Immunother
; 66(4): 461-473, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011996
5.
SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers.
Tumour Biol
; 36(6): 4433-40, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25608839
6.
CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients.
Cancer Immunol Immunother
; 62(1): 113-24, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22842611
7.
Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.
Haematologica
; 103(10): e458-e461, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748439
8.
Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.
Haematologica
; 102(7): e257-e260, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28360148
9.
CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations.
Eur J Haematol
; 87(1): 80-6, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21443542
10.
In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia.
Front Oncol
; 11: 598319, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34381700
11.
CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.
Haematologica
; 95(5): 768-75, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20145264
12.
The effect of ibrutinib on neutrophil and γδ T cell functions.
Leuk Lymphoma
; 61(10): 2409-2418, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306816
13.
SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression.
Br J Haematol
; 140(1): 117-9, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18005265
14.
Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis.
Leuk Lymphoma
; 52(10): 1936-41, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21718136